Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 7:22 PM ET


Company Overview of Elixir Pharmaceuticals, Inc.

Executive Profile

Paul M. Martha Jr., M.D.

Chief Executive Officer, President, Chief Medical Officer and Director, Elixir Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Paul M. Martha, Kip, Jr., M.D. has been the Chief Executive Officer and President of Elixir Pharmaceuticals, Inc. since January 2009 and oversees its Phase III program for GlinsunaTM(mitiglinide calcium hydrate) and MetglunaTM(mitiglinide plus metformin). Dr. Martha has been the Chief Medical Officer of Elixir Pharmaceuticals, Inc. from October 25, 2007. He served as Senior Vice President of Clinical Development & Regulatory Affairs at Elixir Pharmaceuticals, Inc. He ...

Corporate Headquarters

300 Putnam Avenue
Cambridge, Massachusetts 02139

United States

Phone: 617-995-7000
Fax: 617-995-7050

Board Members Memberships

Chief Executive Officer, President, Chief Medical Officer and Director


Unknown/Other Education
University of Connecticut School of Medicine
University of Connecticut School of Medicine
Trinity College
Trinity College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elixir Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at